Breast Cancer Screening

Hologic Receives Approvable Letter For Lorad

Published in Cancer Weekly, November 27th, 2001

Hologic, Inc., (HOLX) has received an approvable letter from the U.S. Food and Drug Administration (FDA) for its Lorad Full Field Digital Mammography System. The Pre-market Application submission for Lorad was based on three years of clinical data gathered and analyzed at some of the world's leading medical institutions.

Utilizing CCD-based technology, Lorad is designed to generate digital mammographic images that can be used for the screening and diagnosis of breast cancer. The American Cancer Society estimates that in 2001, approximately 192,000 new cases of breast cancer will be diagnosed among women in the United States and 40,000 women will die of breast...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-11-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry